Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L LOVE

Showing results (311-320 of 323) with videos related to

Pageof 33
Sort By:
Neurobiology of Disease|June 9, 2026
Human TDP-43 expression worsens FTD-related phenotypes in progranulin-insufficient miceAnna K Cook, Benjamin Lin, Yumo Song, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 21, 2025
ACE trial design: Equol targeting estrogen receptor-β in vascular and cognitive agingAkira Sekikawa, Whitney Wharton, Cristina Murray-Krezan, et al.
The Oncologist|March 8, 2019
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and CanadaBrian Chen, Sumimasa Nagai, James O Armitage, et al.
Neuropharmacology|July 8, 2008
Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areasKenneth W Perry, Julie F Falcone, Matthew J Fell, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulatorJunliang Hao, Veronique Dehlinger, Adam M Fivush, et al.
The Journal of Community and Supportive Oncology|March 9, 2016
Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social networkKamaljeet Kaur, Raja Fayad, Arpit Saxena, et al.
European Heart Journal|May 12, 2026
Molecular mechanism leading to human coronary atherosclerosis assessed by proteomic analysis and RNA sequencesSarah J Parker, Chunhong Mao, David L Caudell, et al.
Neuropharmacology|November 6, 2017
Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disordersRobert F Bruns, Stephen N Mitchell, Keith A Wafford, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2013
Genetic heterogeneity of diffuse large B-cell lymphomaJenny Zhang, Vladimir Grubor, Cassandra L Love, et al.
Blood|September 28, 2019
The whole-genome landscape of Burkitt lymphoma subtypesRazvan I Panea, Cassandra L Love, Jennifer R Shingleton, et al.
Pageof 33

Showing results (311-320 of 323) with videos related to

Sort By:
Pageof 33
Neurobiology of Disease|June 9, 2026
Human TDP-43 expression worsens FTD-related phenotypes in progranulin-insufficient miceAnna K Cook, Benjamin Lin, Yumo Song, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 21, 2025
ACE trial design: Equol targeting estrogen receptor-β in vascular and cognitive agingAkira Sekikawa, Whitney Wharton, Cristina Murray-Krezan, et al.
The Oncologist|March 8, 2019
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and CanadaBrian Chen, Sumimasa Nagai, James O Armitage, et al.
Neuropharmacology|July 8, 2008
Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areasKenneth W Perry, Julie F Falcone, Matthew J Fell, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulatorJunliang Hao, Veronique Dehlinger, Adam M Fivush, et al.
The Journal of Community and Supportive Oncology|March 9, 2016
Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social networkKamaljeet Kaur, Raja Fayad, Arpit Saxena, et al.
European Heart Journal|May 12, 2026
Molecular mechanism leading to human coronary atherosclerosis assessed by proteomic analysis and RNA sequencesSarah J Parker, Chunhong Mao, David L Caudell, et al.
Neuropharmacology|November 6, 2017
Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disordersRobert F Bruns, Stephen N Mitchell, Keith A Wafford, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2013
Genetic heterogeneity of diffuse large B-cell lymphomaJenny Zhang, Vladimir Grubor, Cassandra L Love, et al.
Blood|September 28, 2019
The whole-genome landscape of Burkitt lymphoma subtypesRazvan I Panea, Cassandra L Love, Jennifer R Shingleton, et al.
Pageof 33